CompletedPhase 4

Respiratory Depression of Remimazolam vs. Propofol for Monitored Anesthesia Care

South Korea76 participantsStarted 2023-08-24

Plain-language summary

The comparison of incidence of respiratory depression between remimazolam and propofol under monitored anesthesia care for hysteroscopic surgery

Who can participate

Age range19 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ASA PS 1-2 * Elective hysteroscopic surgery under monitored anesthesia care * No drug abuse history Exclusion Criteria: * BMI \> 30 kg/m2 * Hepatic or renal insufficiency * Alcohol abuse * Respiratory, hemodynamic compromise, or diseases * History of general/regional anesthesia during the last month * A patient who is taking sedatives or analgesics * Under the investigator's judgment

What they're measuring

Respiratory insufficiency before surgery

Timeframe: From the beginning of drug infusion until the moment of starting surgery (assessed up to 30 minutes)

Respiratory insufficiency during surgery

Timeframe: From the beginning of the surgery until the end of the drug infusion (assessed up to 60 minutes)

Trial details

NCT IDNCT07076628

SponsorDongGuk University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-30

View on ClinicalTrials.gov More Propofol trials